3986
Z. Xu et al.
PAPER
3-(3,4,5-Trimethoxybenzyl)-6-(trifluoromethyl)-1H-indole (4h)
Purified by FCC (PE–EtOAc, 4:1); mp 138–139 °C.
IR (KBr): 3132, 3094, 3045, 2921, 2854, 2812, 1724, 1620, 1493,
1462, 1415, 1371, 1292, 1122, 1101, 897, 817, 784, 769, 727 cm–1.
IR (CHCl3): 3348, 1933, 1590, 1504, 1457, 1421, 1332, 1233, 1157,
1103, 1051, 1001, 915, 813 cm–1.
1H NMR (500 MHz, CDCl3): d = 8.53 (br s, 1 H), 7.64 (s, 1 H), 7.61
(d, J = 8.5 Hz, 1 H), 7.33 (dd, J = 1.0, 8.5 Hz, 1 H), 7.09 (d, J = 2.0
Hz, 1 H), 6.52 (s, 2 H), 4.08 (s, 2 H), 3.85 (s, 3 H), 3.80 (s, 6 H).
13C NMR (125 MHz, CDCl3): d = 153.1, 136.5, 136.1, 135.3, 129.6,
125.2 (q, J = 271.5 Hz), 125.2, 124.0 (q, J = 31.8 Hz), 119.3, 115.9
(q, J = 3.5 Hz), 115.7, 108.7 (q, J = 4.4 Hz), 105.6, 60.8, 56.0, 31.8.
1H NMR (300 MHz, CDCl3): d = 8.87 (br s, 1 H), 8.48 (dd, J = 1.2,
4.5 Hz, 1 H), 7.63 (dd, J = 1.2, 8.1 Hz, 1 H), 7.25 (d, J = 2.7 Hz, 1
H), 7.09 (dd, J = 4.5, 8.1 Hz, 1 H), 2.87 (t, J = 7.2 Hz, 2 H), 1.76 (m,
2 H), 1.36 (m, 4 H), 0.88 (t, J = 6.9 Hz, 3 H).
13C NMR (75 MHz, CD3OD): d = 145.6, 141.9, 131.3, 127.5, 120.3,
117.2, 116.8, 32.9, 31.2, 24.8, 23.7, 14.5.
HRMS (ESI): m/z calcd for C12H17N2 (M + H)+: 189.13863; found:
189.13787.
HRMS (ESI): m/z calcd for C19H18F3NO3 + Na (M + Na)+:
388.1136; found: 388.1128.
3-Phenyl-1H-pyrrolo[3,2-b]pyridine (7b)
Purified by FCC (PE–EtOAc, 4:1); oil.
3-(3,4,5-Trimethoxybenzyl)-5-nitro-1H-indole (4i)
Purified by FCC (PE–EtOAc, 5:2); mp 167–168 °C.
1H NMR (300 MHz, CD3OD): d = 8.36 (dd, J = 1.5, 4.8 Hz, 1 H),
7.93 (dt, J = 2.0, 8.1 Hz, 2 H), 7.83 (dd, J = 1.5, 8.1 Hz, 1 H), 7.82
(s, 1 H), 7.39 (m, 2 H), 7.25–7.17 (m, 2 H).
13C NMR (125 MHz, CD3OD): d = 144.4, 143.5, 135.7, 131.7,
129.5, 128.3, 127.6, 126.9, 120.6, 117.8, 117.5.
HRMS (ESI): m/z calcd for C13H11N2 (M + H)+: 195.09168; found:
195.09231.
IR (CHCl3): 3338, 2927, 1591, 1506, 1458, 1421, 1327, 1239, 1125,
1002, 812 cm–1.
1H NMR (500 MHz, CDCl3): d = 8.76 (br s, 1 H), 8.54 (d, J = 2.0
Hz, 1 H), 8.08 (dd, J = 2.0, 9.0 Hz, 1 H), 7.38 (d, J = 9.0 Hz, 1 H),
7.09 (s, 1 H), 6.52 (s, 2 H), 4.08 (s, 2 H), 3.84 (s, 3 H), 3.81 (s, 6 H).
13C NMR (125 MHz, CDCl3): d = 153.3, 141.6, 139.4, 136.4, 135.8,
3-Pentyl-1H-pyrrolo[2,3-c]pyridine (7c)
Purified by FCC (CH2Cl2–MeOH, 15:1); oil.
126.8, 125.4, 118.3, 117.8, 116.4, 111.1, 105.7, 60.9, 56.1, 31.7.
HRMS (ESI): m/z calcd for C18H18N2O5 + Na (M + Na)+: 365.1113;
found: 365.1097.
IR (KBr): 3141, 3091, 2956, 2924, 2854, 2766, 1615, 1501, 1459,
1219, 1123, 1037, 1025, 888, 809, 790 cm–1.
3-Phenyl-1H-indole-5-carbonitrile (4j)
Purified by FCC (PE–EtOAc, 5:1); mp 158–159 °C.
1H NMR (300 MHz, CDCl3): d = 10.93 (br s, 1 H), 8.80 (s, 1 H),
8.22 (d, J = 5.4 Hz, 1 H), 7.54 (d, J = 5.4 Hz, 1 H), 7.24 (s, 1 H),
2.74 (t, J = 7.5 Hz, 2 H), 1.70 (m, 2 H), 1.36 (m, 4 H), 1.90 (t, J = 7.2
Hz, 3 H).
13C NMR (75 MHz, CDCl3): d = 136.5, 133.9, 133.6, 132.6, 126.6,
116.3, 113.9, 31.7, 29.9, 24.7, 22.5, 14.0.
IR (CHCl3): 3287, 2221, 1600, 1544, 1468, 1450, 1427, 1359, 1265,
1246, 1113, 970, 912, 876 cm–1.
1H NMR (300 MHz, CDCl3): d = 8.83 (br s, 1 H), 8.27 (s, 1 H), 7.61
(d, J = 7.2 Hz, 2 H), 7.46–7.52 (m, 5 H), 7.36 (t, J = 7.2 Hz, 1 H).
13C NMR (75 MHz, CDCl3): d = 138.3, 134.0, 129.0, 127.5, 126.7,
125.7, 125.6, 125.1, 123.8, 120.8, 119.1, 112.4, 103.1.
HRMS (ESI): m/z calcd for C12H17N2 (M + H)+: 189.13863; found:
189.13785.
HRMS (ESI): m/z calcd for C16H14N2O + Na (M + MeOH + Na)+:
273.1004; found: 273.1009.
3-Phenyl-1H-pyrrolo[2,3-c]pyridine (7d)
Purified by FCC (CH2Cl2–MeOH, 12:1); oil.
1H NMR (300 MHz, CD3OD): d = 8.72 (s, 1 H), 8.12 (d, J = 5.4 Hz,
1 H), 7.86 (dd, J = 0.9, 5.4 Hz, 1 H), 7.79 (br s, 1 H), 7.65 (dt,
J = 1.5, 8.7 Hz, 2 H), 7.24 (dt, J = 1.5, 8.7 Hz, 2 H), 7.26 (tt, J = 1.5,
8.7 Hz, 1 H).
13C NMR (125 MHz, CD3OD): d = 138.4, 136.0, 135.6, 135.1,
131.9, 129.9, 128.7, 128.1, 127.2, 118.2, 115.6.
3-Hexyl-6-nitro-1H-indole (4k)
Purified by FCC (PE–EtOAc, 16:1); mp 102–103 °C.
IR (CHCl3): 3360, 2921, 2856, 1501, 1463, 1325, 1103, 1057, 877,
831 cm–1.
1H NMR (300 MHz, CDCl3): d = 8.57 (br s, 1 H), 8.36 (d, J = 2.1
Hz, 1 H), 8.01 (dd, J = 2.1, 9.0 Hz, 1 H), 7.63 (d, J = 9.0 Hz, 1 H),
7.29 (d, J = 2.4 Hz, 1 H), 2.76 (t, J = 7.2 Hz, 2 H), 1.70 (m, 2 H),
1.28–1.42 (m, 6 H), 0.89 (t, J = 7.2 Hz, 3 H).
HRMS (ESI): m/z calcd for C13H11N2 (M + H)+: 195.09168; found:
195.09213.
13C NMR (75 MHz, CDCl3): d = 143.1, 134.7, 132.4, 127.3, 118.8,
5-Chloro-3-phenyl-1H-pyrrolo[2,3-b]pyridine (7e)
Purified by FCC (PE–EtOAc, 4:1); oil.
118.3, 114.6, 108.1, 31.7, 30.0, 29.2, 24.8, 22.6, 14.1.
HRMS (ESI): m/z calcd for C14H18N2O2 + Na (M + Na)+: 269.1266;
found: 269.1268.
IR (KBr): 3451, 3120, 3023, 2879, 1599, 1565, 1531, 1478, 1410,
1275, 1126, 910, 758, 699, 664 cm–1.
1H NMR (300 MHz, DMSO-d6): d = 12.22 (s, 1 H), 8.34 (d, J = 2.1
Hz, 1 H), 8.30 (d, J = 2.1 Hz, 1 H), 8.01 (d, J = 2.7 Hz, 1 H), 7.74
(dt, J = 1.5, 8.4 Hz, 2 H), 7.46 (dt, J = 1.5, 8.4 Hz, 2 H), 7.28 (tt,
J = 1.5, 8.4 Hz, 1 H).
13C NMR (75 MHz, DMSO-d6): d = 147.4, 141.0, 134.3, 128.9,
126.6, 126.3, 126.0, 125.8, 123.0, 118.1, 114.2.
3-Pentyl-1H-pyrrolo[3,2-b]pyridine (7a); Typical Procedure
A solution of 3-amino-2-chloropyridine (6a; 39 mg, 0.3 mmol),
heptanal (103 mg, 0.9 mmol), and DABCO (101 mg, 0.9 mmol) in
anhyd DMA (1.5 mL) was degassed for 20 min. Pd(dba)2 (8.6 mg,
0.015 mmol) and t-Bu3P·HBF4 (8.7 mg, 0.03 mmol) were added,
and the resulting mixture was heated at 150 °C for 9 h. The mixture
was cooled to r.t. and diluted with H2O (15 mL). The aqueous phase
was extracted with EtOAc (2 × 15 mL). The combined organic
phases were washed with brine (3 × 15 mL), dried (Na2SO4), and
evaporated to dryness under reduced pressure. Purification of the
crude product by FCC (PE–EtOAc, 4:1) provided the desired prod-
uct 7a; yield: 25 mg (44%); oil (Table 3).
5-(Trifluoromethyl)-3-phenyl-1H-pyrrolo[2,3-b]pyridine (7f)
Purified by FCC (PE–EtOAc, 4:1); mp 209–211 °C.
IR (CHCl3): 3129, 2883, 1591, 1536, 1348, 1307, 1281, 1114, 1070,
973, 916, 902, 829 cm–1.
Synthesis 2008, No. 24, 3981–3987 © Thieme Stuttgart · New York